IP Library › Assignment 033175/0547
Patent Assignment
Reel/Frame 033175/0547

Assignment of Assignor's Interest

Recorded: 2014-06-10 Pages: 6
Assignor
THERAVANCE, INC.
Executed: 2014-05-31
Assignee
THERAVANCE RESPIRATORY COMPANY, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080
Covered Properties (4)
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Application: 61/172,039 →
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Patent: 8,816,088 →
Application: 13/964,484 →
Publication: US 2013/0331364
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta-2 Adrenergic Receptor Agonist Activity
Patent: 8,138,345 →
Application: 12/761,532 →
Publication: US 2010/0273755
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Patent: 8,551,978 →
Application: 13/369,109 →
Publication: US 2013/0137665
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 21, 2009
From: HUGHES, ADAM; BYUN, DANIEL; CHEN, YAN; FLEURY, MELISSA
To: THERAVANCE, INC.
Reel/Frame 023405/0551 →
Assignment of Assignor's Interest Apr 16, 2010
From: HUGHES, ADAM; BYUN, DANIEL; CHEN, YAN; FLEURY, MELISSA
To: THERAVANCE, INC.
Reel/Frame 024245/0275 →
Assignment of Assignor's Interest Nov 12, 2020
From: THERAVANCE RESPIRATORY COMPANY, LLC
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 054393/0695 →